{"page_content": "37      KODIAK 2021 ESG REPORT BACK TO CONTENTS >>KODIAK 2021 SASB INDEX\nSASB SUSTAINABILITY ACCOUNTING STANDARDS 2018\nTopic SASB Code Accounting or Activity Metric Response, Cross-reference, or Omission Source(s)\nActivity Metrics\nHC-BP-000.A Number of patients treatedKodiak does not report on this metric at this \ntimeN/A\nHC-BP-000.BNumber of drugs (1) in portfolio and (2) in \nresearch and development (Phases 1-3)Relevant information can be found in the  \nOur Products section of our website and the \nItem 1 \"Business\" section of 2021 10-KOur Products Webpage\n2021 10-K, p. 1-3\n2021 ESG Report, \nResearch and \nDevelopment, p. 17", "metadata": {"source": "NASDAQ_KOD_2021.pdf", "page": 36, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}